GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Pre-Tax Income

Aprinoia Therapeutics (Aprinoia Therapeutics) Pre-Tax Income : $-21.68 Mil (TTM As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Aprinoia Therapeutics's pretax income for the six months ended in Jun. 2023 was $-7.13 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-21.68 Mil. Aprinoia Therapeutics's pretax margin was -78.95%.

Aprinoia Therapeutics Pre-Tax Income Historical Data

The historical data trend for Aprinoia Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Pre-Tax Income Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Pre-Tax Income
-23.26 -28.21

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Pre-Tax Income - -13.67 -14.54 -7.13

Competitive Comparison of Aprinoia Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Aprinoia Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aprinoia Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aprinoia Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Aprinoia Therapeutics's Pre-Tax Income falls into.


Aprinoia Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Aprinoia Therapeutics's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-28.264+0.117+-0.067+0+0
=-28.21

Aprinoia Therapeutics's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-6.737+1.049+-1.444+0+1.7763568394003E-15
=-7.13

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-21.68 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics  (NAS:APRI) Pre-Tax Income Explanation

Aprinoia Therapeutics's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-7.132/9.034
=-78.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Pre-Tax Income
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines